WHO WE ARE
We are diverse. We are driven and innovative. And we operate without ego.
We trust in our power to think independently and our capacity to act.
We are pioneers.
What We Do
We mine the human genome, identifying mutations in genes that increase the risk for neuro-degenerative diseases and cancer. Then we develop drugs that counteract the damage done by these mutations.
We are unified around the common goal of creating disruptive change in the way the world treats these diseases.
Why We Do It
What we’re doing is hard, but necessary. We are committed to disease states where nothing has worked or where there is opportunity to do much better.
We believe that what we do matters.